Brief Information of the Cell Line and Protein
Cell Line ID: CL000174 , Raji
Synonyms
RAJI
P1-Raji
GM04671
Category Cancer cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_0511
Protein ID: PT03838 , Proteasome subunit beta type-9
Gene Name PSMB9
Organism Homo sapiens, Human
Protein Classification Enzyme
Uniprot ID P28065
Table of Molecular Bioactivities Related to the Cell Line and Protein
Cell Line ID: CL000174  Protein ID: PT03838
 
Compound ID Compound Name Compound Formula
CP0907727
(2S,4R)-1-((S)-2-(2-azidoacetamido)propanoyl)-4-fluoro-N-((S)-1-((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-ylamino)-1-oxohexan-2-yl)pyrrolidine-2-carboxamide
   Show/Hide
C25H40FN7O6
 1
1
IC50 = 22 nM
   TI
   LI
   LO
   TS
CP0885655
(S)-1-((S)-2-(2-azidoacetamido)propanoyl)-4,4-difluoro-N-((S)-1-((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-ylamino)-1-oxohexan-2-yl)pyrrolidine-2-carboxamide
   Show/Hide
C25H39F2N7O6
 1
1
IC50 = 34 nM
   TI
   LI
   LO
   TS
CP0411617
(2S)-1-[(2S)-2-[(2-azidoacetyl)amino]propanoyl]-4,4-difluoro-N-[(2S)-1-[[(2S)-1-[(2R)-2-methyloxiran-2-yl]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxohexan-2-yl]pyrrolidine-2-carboxamide
   Show/Hide
C28H37F2N7O6
 1
1
IC50 = 42 nM
   TI
   LI
   LO
   TS
CP0399509
(2S)-1-[(2S)-2-[(2-azidoacetyl)amino]propanoyl]-N-[(2S)-1-[[(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]pyrrolidine-2-carboxamide
   Show/Hide
C25H41N7O6
 1
1
IC50 = 45 nM
   TI
   LI
   LO
   TS
CP0448436
(2S)-1-[(2S)-2-[(2-azidoacetyl)amino]propanoyl]-N-[(2S)-1-[[(2S)-1-[(2R)-2-methyloxiran-2-yl]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxohexan-2-yl]pyrrolidine-2-carboxamide
   Show/Hide
C28H39N7O6
 1
1
IC50 = 66 nM
   TI
   LI
   LO
   TS
CP0907726
(S)-1-((S)-2-(2-azidoacetamido)propanoyl)-N-((S)-1-((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-ylamino)-1-oxohexan-2-yl)piperidine-2-carboxamide
   Show/Hide
C26H43N7O6
 1
1
IC50 = 67 nM
   TI
   LI
   LO
   TS
CP0928336
(R)-3-((S)-2-(2-azidoacetamido)propanoyl)-N-((S)-1-((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-ylamino)-1-oxohexan-2-yl)thiazolidine-4-carboxamide
   Show/Hide
C24H39N7O6S
 1
1
IC50 = 68 nM
   TI
   LI
   LO
   TS
CP0448437
(2S)-1-[(2S)-2-[(2-azidoacetyl)amino]propanoyl]-N-[(2S)-1-[[(2S)-3-cyclohexyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]pyrrolidine-2-carboxamide
   Show/Hide
C28H45N7O6
 1
1
IC50 = 87 nM
   TI
   LI
   LO
   TS
CP0475672
(2S)-1-[(2S)-2-[(2-azidoacetyl)amino]propanoyl]-N-[(2S)-1-[[(2S)-3-cyclohexyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]-4,4-difluoropyrrolidine-2-carboxamide
   Show/Hide
C28H43F2N7O6
 1
1
IC50 = 95 nM
   TI
   LI
   LO
   TS
CP0945820
(S)-1-((S)-2-(2-azidoacetamido)propanoyl)-N-((S)-1-((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-ylamino)-1-oxohexan-2-yl)azetidine-2-carboxamide
   Show/Hide
C24H39N7O6
 1
1
IC50 = 96 nM
   TI
   LI
   LO
   TS
CP0411616
N-[(2S)-1-[[(2S)-1-[(2S)-2-[[tert-butyl(dimethyl)silyl]oxymethyl]oxiran-2-yl]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]heptanamide
   Show/Hide
C25H48N2O5Si
 1
1
IC50 = 104 nM
   TI
   LI
   LO
   TS
CP0850424
(2S,4R)-1-((S)-2-(2-azidoacetamido)propanoyl)-4-hydroxy-N-((S)-1-((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-ylamino)-1-oxohexan-2-yl)pyrrolidine-2-carboxamide
   Show/Hide
C25H41N7O7
 1
1
IC50 = 170 nM
   TI
   LI
   LO
   TS
CP0864820
(2S,4S)-1-((S)-2-(2-azidoacetamido)propanoyl)-4-fluoro-N-((S)-1-((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-ylamino)-1-oxohexan-2-yl)pyrrolidine-2-carboxamide
   Show/Hide
C25H40FN7O6
 1
1
IC50 = 220 nM
   TI
   LI
   LO
   TS
CP0885679
(S)-N-((S)-3-cyclohexyl-1-((R)-2-methyloxiran-2-yl)-1-oxopropan-2-yl)-3-(4-methoxyphenyl)-2-((S)-2-(2-morpholinoacetamido)propanamido)propanamide
   Show/Hide
C31H46N4O7
 1
1
IC50 = 300 nM
   TI
   LI
   LO
   TS
CP0062987
(2S)-3-(4-methoxyphenyl)-N-[(2S)-1-[(2R)-2-methyloxiran-2-yl]-1-oxo-3-phenylpropan-2-yl]-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide
   Show/Hide
C31H40N4O7
 1
1
IC50 = 460 nM
   TI
   LI
   LO
   TS
CP0847941
N-((R)-1-((S)-3-(1H-indol-3-yl)-1-((S)-1-((R)-2-methyloxiran-2-yl)-1-oxo-3-phenylpropan-2-ylamino)-1-oxopropan-2-ylamino)-1-oxopropan-2-yl)-3-methyl-1H-indene-2-carboxamide
   Show/Hide
C37H38N4O5
 1
1
IC50 = 1840 nM
   TI
   LI
   LO
   TS
CP0868641
N-((R)-1-((S)-1-((S)-3-cyclohexyl-1-((R)-2-methyloxiran-2-yl)-1-oxopropan-2-ylamino)-3-(1H-indol-3-yl)-1-oxopropan-2-ylamino)-1-oxopropan-2-yl)-3-methyl-1H-indene-2-carboxamide
   Show/Hide
C37H44N4O5
 1
1
IC50 = 7100 nM
   TI
   LI
   LO
   TS
CP0386861
(2S)-N-[(2S)-3-cyclohexyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-(4-methoxyphenyl)-2-[[(2R)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide
   Show/Hide
C31H46N4O7
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0411613
N-[(2R)-1-[[(2S)-1-[[(2S)-3-cyclohexyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]amino]-3-(4-methoxyphenyl)-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]-3-methyl-1H-indene-2-carboxamide
   Show/Hide
C36H45N3O6
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0864816
(S)-N-((S)-3-cyclohexyl-1-((R)-2-methyloxiran-2-yl)-1-oxopropan-2-yl)-3-(1H-indol-3-yl)-2-((R)-2-(2-morpholinoacetamido)propanamido)propanamide
   Show/Hide
C32H45N5O6
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0850423
N-((R)-1-((S)-3-(1H-indol-3-yl)-1-((S)-4-(methylsulfonyl)-1-phenylbut-3-en-2-ylamino)-1-oxopropan-2-ylamino)-1-oxopropan-2-yl)-3-methyl-1H-indene-2-carboxamide
   Show/Hide
C36H38N4O5S
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS